# METIS innovative

> METIS innovative is a VC fund backing Medical and Medical Device. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Miami Beach, United States
- Total investments: 7
- Last investment: Apr 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/metis-innovative/about/
- Website: https://www.metisinnovative.com/

METIS innovative is a VC fund in Miami Beach focused on Medical and Medical Device. Metis Innovative was formed in 2017 as an investment vehicle for promising early stage medical devices and technology in the neurosciences. Founded by two prominent neurosurgeons in academic practice and a veteran of capital accrual for investment opportunities, the firm’s mission is to identify and invest in unique, well positioned companiesfocused on scientific breakthroughs.

## Contacts

5 contacts available for METIS innovative. Shizune tracks 1 team members at METIS innovative. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/metis-innovative?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $19M–$27M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 43% |
| Medical Device | 2 | 29% |
| Robotics | 1 | 14% |
| Health Care | 1 | 14% |
| Neuroscience | 1 | 14% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 29% |
| Seed | 1 | 14% |
| Series B | 1 | 14% |
| Series C | 1 | 14% |
| Series D | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 29% |
| Canada | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Brian Sidman | Co-Founder, Principal; Co-Founder, Principal | 0 | https://shizune.co/investors/profile/brian-sidman |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Phantom Neuro | Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $19M | Series A | Apr 15, 2025 |  |
| Fluid Biomed | Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. | $27M | Series A | Dec 16, 2024 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M | Series C | Dec 16, 2022 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M | Series C | Dec 15, 2022 |  |
| Fluid Biomed | Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. | $4.7M | Seed | Aug 11, 2021 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $40M | Series B | Jun 03, 2021 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $200M | Series D |  |  |

7 of 7 investments shown.

## Co-investors
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 4 deals together
- [Neurotechnology Investors](https://shizune.co/investors/profile/neurotechnology-investors-nti) — VC Fund, 4 deals together
- [Forepont Capital Partners](https://shizune.co/investors/profile/forepont-capital-partners) — VC Fund, 3 deals together
- [ID8 Investments](https://shizune.co/investors/profile/id8-investments) — VC Fund, 3 deals together
- [University of Melbourne](https://shizune.co/investors/profile/the-university-of-melbourne) — VC Fund, 3 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [Medical Device VC Funds in Canada](https://shizune.co/investors/medical-device-vc-funds-canada)

## FAQ

### What does METIS innovative invest in?

METIS innovative invests primarily in Medical, Medical Device and Robotics startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is METIS innovative's check size?

METIS innovative typically joins rounds of $19M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds METIS innovative participates in.

### How do I contact METIS innovative?

Public channels for METIS innovative include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at METIS innovative?

The team at METIS innovative includes Brian Sidman (Co-Founder, Principal; Co-Founder, Principal). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co